The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,261,770 in first-year total cost, median $206,550.
Most frequent study sections
- Special Emphasis Panel[ZHG1 HGR-M (J1)]6
Most frequent institutions
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)1
- EMORY UNIVERSITY1
- ROSWELL PARK CANCER INSTITUTE CORP1
- UNIVERSITY OF KANSAS MEDICAL CENTER1
- UNIVERSITY OF MICHIGAN AT ANN ARBOR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Mutational analysis to understand the role of CHML in developmental regression1R21GM114645-01 | YU, EUGENE | ROSWELL PARK CANCER INSTITUTE CORP, NY | $236,925 | ZHG1 |
| 2015 | Role of FOXR1 in Mammalian Brain Development1R21GM114629-01 | HO, ANGELA | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $220,995 | ZHG1 |
| 2015 | The function of YPEL3 in the nervous system1R21GM114529-01 | YE, BING | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $209,250 | ZHG1 |
| 2015 | Role of a BHLHB9 polymorphism in the etiology of a developmental disorder1R21GM114647-01 | SMITH, PETER GVIVIAN, JAY L | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $203,850 | ZHG1 |
| 2015 | Genetic and functional analysis of YPEL3 and its link to disease1R21GM114438-01 | WESTERFIELD, MONTE | UNIVERSITY OF OREGON, OR | $195,750 | ZHG1 |
| 2015 | BAI2 mutation associated with a novel neurological disorder1R21NS094136-01 | HALL, RANDY A. | EMORY UNIVERSITY, GA | $195,000 | ZHG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.